| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 09/30/2004 | US20040191227 Induction of immunological tolerance |
| 09/30/2004 | US20040191170 Evaluation of infections by enteric pathogens including diarrhea caused by Escherichia and are hemorrhagic |
| 09/30/2004 | DE10311248A1 Humaner monoklonaler Antikörper Human monoclonal antibodies |
| 09/30/2004 | CA2519620A1 Humanized anti-cd4 antibody with immunosuppressive properties |
| 09/30/2004 | CA2519258A1 Construct comprising region recognized by antibody against von willebrand factor-specific cleaving protease |
| 09/30/2004 | CA2518980A1 Antibodies to igf-i receptor for the treatment of cancers |
| 09/30/2004 | CA2518371A1 Antibodies against human il-21 receptor and uses therefor |
| 09/29/2004 | EP1462521A1 Human p53 splice variant displaying differential transcriptional activity |
| 09/29/2004 | EP1462457A1 Cytotoxic protein and utilization thereof |
| 09/29/2004 | EP1462456A1 Tumor antigens |
| 09/29/2004 | EP1462114A1 Methods and means to suppress symptons of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (GRIT or TNFRSF18) |
| 09/29/2004 | EP1462113A1 CELL GROWTH INHIBITOR CONTAINING ANTI-PepT ANTIBODY |
| 09/29/2004 | EP1461446A2 Lipid-associated molecules |
| 09/29/2004 | EP1461443A2 Carbohydrate-associated proteins |
| 09/29/2004 | EP1461442A2 TRANSGENIC ANIMALS BEARING HUMAN Ig Lambda LIGHT CHAIN GENES |
| 09/29/2004 | EP1461428A2 Hybrid antibodies |
| 09/29/2004 | EP1461423A2 Antibody categorization based on binding characteristics |
| 09/29/2004 | EP1461360A2 Conjugates comprising an antibody specific for the ed-b domain of fibronectin and their use for the detection and treatment of tumours |
| 09/29/2004 | EP1461359A2 Novel anti-igf-ir antibodies and uses thereof |
| 09/29/2004 | EP1461357A2 Novel hev antigenic peptide and methods |
| 09/29/2004 | EP1461351A2 Methods and reagents for diagnosis and treatment of diabetes |
| 09/29/2004 | EP1461300A2 Antibodies against monocyte chemotactic proteins |
| 09/29/2004 | EP1461082A2 Antibodies against carboxic anhydrase ix (ca ix) tumor antigen |
| 09/29/2004 | EP1461081A2 Anti-cd45rb antibodies for use in treating autoimmune disease and transplant rejection |
| 09/29/2004 | EP1461079A2 Human immunodeficiency virus envelope clycoprotein mutants and uses thereof |
| 09/29/2004 | EP1461074A2 Agents for enhancing the immune response |
| 09/29/2004 | EP1461073A2 Peptide agonists of prostate-specific antigen, and uses therefor |
| 09/29/2004 | EP1461071A1 Muscle transcription factors |
| 09/29/2004 | EP1461023A2 Prospective identification and characterization of breast cancer stem cells |
| 09/29/2004 | EP1461001A2 Cancer-associated epitope |
| 09/29/2004 | EP1412752A4 Methods and compositions for determining the purity of and purifying chemically synthesized nucleic acids |
| 09/29/2004 | EP1137808B1 Methods for making recombinant cells |
| 09/29/2004 | EP1084147B1 Process for producing immunoglobulins for intravenous administration and other immunoglobulin products |
| 09/29/2004 | EP0980426B1 TYROSINE PHOSPHORYLATED CLEAVAGE FURROW-ASSOCIATED PROTEINS (PSTPIPs) |
| 09/29/2004 | EP0914417B1 Human dnase ii |
| 09/29/2004 | EP0826006B1 Transepithelial transport of molecular species |
| 09/29/2004 | EP0675903B1 Bone resorption assay |
| 09/29/2004 | CN1533440A Use of P2Y purinergic receptor expression for identifying preneoplastic and neoplastic states |
| 09/29/2004 | CN1533285A Adjuvant combination formulations |
| 09/29/2004 | CN1532286A Method for detecting or determining HCV core antigen and reagent for detecting and determining used thereof |
| 09/29/2004 | CN1168741C Monoclonal antibody anti alpha; V-integrin and it use to inhibit alpha; beta; 6-integrain attachment to fibronectine |
| 09/28/2004 | US6797814 Protein purification |
| 09/28/2004 | US6797812 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of ischemic injury, nervous system and inflammatory disorders |
| 09/28/2004 | US6797811 Antibodies to chemokine receptor 88C |
| 09/28/2004 | US6797696 Contacting a bodily fluid with an antibody which binds to an human aspartyl (asparaginyl) beta-hydroxylase (haah) polypeptide to form a complex and detecting the complex; treating malignant neoplasms by inhibiting haah. |
| 09/28/2004 | US6797690 Anti-freeze polypeptides for improving the freezing tolerance of foodstuffs |
| 09/28/2004 | US6797514 Simultaneous stimulation and concentration of cells |
| 09/28/2004 | US6797513 Nucleic acid encoding CLK2 protein kinases |
| 09/28/2004 | US6797511 Basis of its ability to bind to presenilin 1; for treatment of alzheimer's disease |
| 09/28/2004 | US6797501 Protein tyrosine phosphatase PTP20 and related products and methods |
| 09/28/2004 | US6797499 Isolated human dehydrogenases, nucleic acid molecules encoding these human dehydrogenases, and uses thereof |
| 09/28/2004 | US6797498 B, B-carotene 15, 15′-dioxygenases, nucleic acid sequences coding therefor and their use |
| 09/28/2004 | US6797495 Somatic cells with ablated PrP gene and methods of use |
| 09/28/2004 | US6797492 Method for reducing the immunogenicity of antibody variable domains |
| 09/28/2004 | US6797489 PP14 fusion proteins and methods for making and using the same |
| 09/28/2004 | US6797486 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 09/28/2004 | US6797479 Reagents and methods for the detection and quantification of vancomycin in biological fluids |
| 09/28/2004 | US6797478 For diagnosis of degradation due to head trauma or cns tumor; works in brain but not in cerebrospinal fluid (csf); enzyme-linked immunosorbent assay (elisa) |
| 09/28/2004 | US6797274 Compounds |
| 09/28/2004 | US6797272 Enhanced immunogenicity using leukotoxin chimeras |
| 09/28/2004 | CA2162557C Conserved motif of hepatitis c virus e2/ns1 region |
| 09/26/2004 | CA2424255A1 Immunotoxins |
| 09/25/2004 | CA2462343A1 Genetically biotinylated recombinant antibody in immunofiltration assay by light addressable potentiometric sensor for identification of venezuelan equine encephalitis virus |
| 09/23/2004 | WO2004081569A1 N1,n12-diacetylspermine as tumor marker |
| 09/23/2004 | WO2004081198A2 Methods for modulating angiogenesis with apelin compositions |
| 09/23/2004 | WO2004081190A2 Uses of il-23 agonists and antagonists; related reagents |
| 09/23/2004 | WO2004081187A2 Genetic polymorphisms associated with myocardial infarction, methods of detection and uses thereof |
| 09/23/2004 | WO2004081177A2 Intracellular signaling pathways in diabetic subjects |
| 09/23/2004 | WO2004081174A2 Marker for detecting mesenchymal stem cell and method of distinguishing mesenchymal stem cell using the marker |
| 09/23/2004 | WO2004081053A1 Physiologically active polypeptide conjugate having prolonged in vivo half-life |
| 09/23/2004 | WO2004081051A1 Bispecific antibodies |
| 09/23/2004 | WO2004081050A1 Antibody against tumor specific antigen as target |
| 09/23/2004 | WO2004081049A1 Monoclonal antibodies that recognise mucosal addressin cell adhesion molecule-1 (madcam-1), soluble madcam-1 and uses thereof |
| 09/23/2004 | WO2004081048A1 Ligand having agonistic activity to mutated receptor |
| 09/23/2004 | WO2004081047A1 Monoclonal antibody and hybridoma producing the same |
| 09/23/2004 | WO2004081046A2 Human monoclonal antibodies against apociii and their use in the therapy of atherosclerosis |
| 09/23/2004 | WO2004081044A1 Diagnostics and therapeutics for diseases associated with g-protein coupled protease activated receptor 1 (par1) |
| 09/23/2004 | WO2004081039A1 Novel protein and its dna |
| 09/23/2004 | WO2004081037A1 Inhibitors of extracellular hsp90 |
| 09/23/2004 | WO2004081035A1 Peptide fragment of lyve-1 and antibody against the same |
| 09/23/2004 | WO2004081029A2 Novel non-invasive marker for liver disease |
| 09/23/2004 | WO2004081027A2 Neoplasm specific antibodies and uses thereof |
| 09/23/2004 | WO2004081026A2 Polypeptides |
| 09/23/2004 | WO2004080579A2 Liquid tissue preparation from histopatologically processed biological samples, tissues and cells |
| 09/23/2004 | WO2004080425A2 Polypeptide compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | WO2004080420A2 A method for the prevention of malaria infection of humans by hepatocyte growth factor antagonists |
| 09/23/2004 | WO2004080419A2 Humanized antibodies that recognize beta amyloid peptide |
| 09/23/2004 | WO2004080418A2 Nucleic acid compounds for inhibiting angiogenesis and tumor growth |
| 09/23/2004 | WO2004080394A2 Stat3 antagonists and their use as vaccines against cancer |
| 09/23/2004 | WO2004080385A2 Compositions and methods for diagnosing and treating an inflammation |
| 09/23/2004 | WO2004080375A2 Vaccine therapy of atherosclerosis |
| 09/23/2004 | WO2004080288A2 Post-translational modifications of proteins as regulatory switches |
| 09/23/2004 | WO2004080273A2 Compositions and methods for diagnosing and treating prostate cancer |
| 09/23/2004 | WO2004066914A3 Variant integrin polypeptides and uses thereof |
| 09/23/2004 | WO2004050836A3 Humanized antibodies against monocyte chemotactic proteins |
| 09/23/2004 | WO2004050707A3 Tumor-specific recognition molecules |
| 09/23/2004 | WO2004050120A3 Treatment of prion-induced diseases by administration fo anti-prion antibodies |
| 09/23/2004 | WO2004046185A3 Intracellular antibodies |
| 09/23/2004 | WO2004041155A3 Treatment and prevention of abnormal scar formation in keloids and other cutaneous or internal wounds or lesions |
| 09/23/2004 | WO2004039842A3 Humanized tissue factor antibodies |